- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06739174
Assessment of Colostomy Bags with an Active Chamber Filter System and Incidence of Filter-Related Complication (BREEZE-01)
December 12, 2024 updated by: Salts Healthcare
Three Way Crossover Study: Assessment of Colostomy Bags with an Active Chamber Filter System and Incidence of Filter-Related Complication by People Living with a Colostomy
This 3-way crossover study aims to evaluate whether colostomy bags with an active chamber filter system reduce the incidence of filter-related complications, such as ballooning and pancaking, help neutralise odour, and minimise faecal leakage through the filter compared to colostomy bags with a protective filter
Study Overview
Status
Recruiting
Conditions
Detailed Description
The study will recruit participants living with a colostomy who experience complications related to colostomy bag filters.
The study follows a repeated-measures design, in which each participant will test three types of colostomy bags (A, B, and C) over a 21-day period, divided into three 7-day test periods.
During each test period, participants will use one type of colostomy bag for 7-days or up to 21 closed bags.
Participants will be instructed to change the colostomy bag as often as they normally would or whenever they deem it necessary
Study Type
Interventional
Enrollment (Estimated)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Clinical Research Coordinator
- Phone Number: +44 (0) 121 333 2015
- Email: info@cssinstitute.co.uk
Study Contact Backup
- Name: Clinical Research Nurse
- Phone Number: 07917630767
- Email: sarah.ashworth@salts.co.uk
Study Locations
-
-
England
-
Birmingham, England, United Kingdom, B7 4AA
- Recruiting
- Central Skin Sciences Institute (CSSI) Salts Healthcare
-
Contact:
- Mireille Hamson
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult aged over 18 years
- Colostomy for 6 months or longer
- Experiences any filter-related complications, such as ballooning, pancaking, odour, or faecal leakage through the filter, at least once a week (7 days)
- Independent in colostomy care
- Using a flat, closed colostomy bag
- Stoma size (diameter) less than 55 mm
- Using a colostomy bag with a hydrocolloid wafer (baseplate)
- Able to read and complete the study questionnaire in English
Exclusion Criteria:
- Uses colostomy irrigation
- Bleeding or broken peristomal skin
- Receiving or had radiotherapy or chemotherapy in the last 2 months
- Pregnant or breastfeeding
- Taking part in another clinical study
- Currently receiving treatment under the care of a stoma clinical nurse specialist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Confidence Be 1-Piece Closed Bag
The reference device is CE Marked and already commercially available
|
Active Chamber Filter - Circle Shape
|
|
Active Comparator: Confidence Natural 1-Piece Closed Bag
The reference device is CE Marked and already commercially available
|
Protective Filter - Circle Shape
|
|
Active Comparator: Confidence Be go 1-Piece Closed Bag
The reference device is CE Marked and already commercially available in Australia
|
Active Chamber Filter - Hexagon Shape
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of ballooning
Time Frame: 21-days
|
Evaluation and comparison of the incidence of ballooning in colostomy bags with active chamber filter system and a protective filter
|
21-days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time of ballooning incidence
Time Frame: 21-days
|
Evaluation and comparison of the timing of ballooning over a 24-hour period in colostomy bags with an active chamber filter system and a protective filter
|
21-days
|
|
Wear time until ballooning incidence
Time Frame: 21-days
|
Evaluation and comparison of the wear time duration of colostomy bags with an active chamber filter system and a protective filter until a ballooning incident occurs
|
21-days
|
|
Incidence of pancaking
Time Frame: 21-days
|
Evaluation and comparison of the incidence of pancaking in colostomy bags with an active chamber filter system and a protective filter
|
21-days
|
|
Time of pancaking incidence
Time Frame: 21-days
|
Evaluation and comparison of the timing of pancaking incidents over a 24-hour period in colostomy bags with an active chamber filter system and a protective filter
|
21-days
|
|
Wear time until pancaking incidence
Time Frame: 21-days
|
Evaluation and comparison of the wear time duration of colostomy bags with active chamber filter system and a protective filter until pancaking incident to occur
|
21-days
|
|
Faecal leakage occurrence through the filter
Time Frame: 21-days
|
Evaluation and comparison of faecal leakage occurrence through the filter in colostomy bags with an active chamber filter system and a protective filter
|
21-days
|
|
Occurrence of odour through the filter
Time Frame: 21-days
|
Evaluation and comparison of odour occurrence through the filter in colostomy bags with an active chamber filter system and a protective filter
|
21-days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mireille Hamson, Salt Healthcare
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 29, 2024
Primary Completion (Estimated)
April 30, 2025
Study Completion (Estimated)
April 30, 2025
Study Registration Dates
First Submitted
December 9, 2024
First Submitted That Met QC Criteria
December 12, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 12, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 24/EE/0241
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colostomy - Stoma
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Massachusetts General HospitalCompletedSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
Children Hospital FaisalabadRecruitingERAS | Stoma Reversal Procedure | Colostomy - StomaPakistan
-
Assiut UniversityNot yet recruiting
-
Asian Institute of Gastroenterology, IndiaNot yet recruiting
-
Helsinki University Central HospitalMary and Georg Ehrnrooth's foundation; Helsinki University Hospital Research...Not yet recruitingStoma Ileostomy | Stoma ColostomyFinland
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy StomaDenmark, Sweden
-
Coloplast A/SCompletedStoma Ileostomy | Stoma ColostomyUnited Kingdom
Clinical Trials on Confidence Be 1-Piece Closed Bag
-
Zeynep Kamil Maternity and Pediatric Research and...UnknownPostoperative PainTurkey
-
Coloplast A/SCompleted